UnitedHealth Group released the first results from a sprawling independent audit of its business practices and committed to a ...

UnitedHealth Group shareholders probably want to forget. However, the health insurance giant should see brighter days ahead.

UnitedHealth Group Incorporated is rated a Buy with profits recovering and the foundation set for renewed growth. Learn more ...

UnitedHealth Group (NYSE: UNH) has endured a brutal 2025, with shares down approximately 35% year-to-date. This marks the ...

UnitedHealth Group is selling its last South American business, Banmedica, to Brazilian private equity group Patria Investments for $1 billion, two sources told Reuters on Sunday. The final agreement ...

Unresolved issues at its insurance unit and repeat violations during regulatory audits were some of the findings cited in the first outside reviews commissioned by the managed care giant UnitedHealth ...

The raises for HCSC executives come at a time when insurance premiums are skyrocketing and health care costs continue a ...

Stephen Hemsley was CEO of UnitedHealth Group—a top five public company by revenue—from 2006–17. He stepped away from that role to become chairman but added back CEO responsibilities this past May ...

Shareholders of record by the close of trading on Monday, December 8, 2025, will be eligible for a quarterly cash distribution of $2.21 per share, payable on December 16. At the current share price ...

After navigating through a series of recent challenges, UNH has demonstrated stability and is now poised for renewed growth. This article delves into the key factors contributing to UNH’s recovery, ...

In the latest trading session, UnitedHealth Group (UNH) closed at $319.97, marking a +2.71% move from the previous day. The stock's performance was ahead of the S&P 500's daily gain of 0.98%.